Simona Alibrandi
The application of sequencing technologies has steadily increased over the past few years. This has allowed an exponential amplification of the information available in genome databases. Therefore, more accurate data are now available to perform disease association studies. This brief communication aims to highlight the roles of single-nucleotide polymorphisms in the development of pathological phenotypes.
